Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Treasury Shares (2019 - 2021)

Rein Therapeutics filings provide 3 years of Treasury Shares readings, the most recent being $250000.0 for Q1 2021.

  • For the quarter ending Q1 2021, Treasury Shares rose 400.0% year-over-year to $250000.0, compared with a TTM value of $250000.0 through Mar 2021, up 400.0%, and an annual FY2019 reading of $50000.0, changed N/A over the prior year.
  • Treasury Shares hit $250000.0 in Q1 2021 for Rein Therapeutics, up from $10000.0 in the prior quarter.
  • The five-year high for Treasury Shares was $250000.0 in Q1 2021, with the low at $10000.0 in Q2 2020.
  • Median Treasury Shares over the past 3 years was $50000.0 (2019), compared with a mean of $76666.7.
  • The sharpest move saw Treasury Shares tumbled 80.0% in 2020, then skyrocketed 400.0% in 2021.
  • Year by year, Treasury Shares stood at $50000.0 in 2019, then plummeted by 80.0% to $10000.0 in 2020, then skyrocketed by 2400.0% to $250000.0 in 2021.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $250000.0, $10000.0, and $50000.0 for Q1 2021, Q2 2020, and Q1 2020 respectively.